BIA calls on government to support an attractive UK commercial environment for medicines
The UK BioIndustry Association (BIA) has today published a report calling for the next Voluntary Pricing and Access Scheme (VPAS) to build on the spirit of partnership between government and the life sciences industry seen during the COVID-19 pandemic.Making VPAS fit for the future: the BIA vision, which has been developed with Oxygen Strategy, identifies the risk of the UK losing its status as a first launch market for new medicines following a period of post-Brexit political uncertainty and